This is a non-core endpoint: only basic statistics are computed.
Carcinoma in situ of breast, lobular
CD2_INSITU_BREAST_LOBULAR
breast ductal carcinoma in situ: A carcinoma entirely confined to the mammary ducts. It is also known as DCIS. There is no evidence of invasion of the basement membrane. Currently, it is classified into three categories: High-grade DCIS, intermediate-grade DCIS and low-grade DCIS. In this classification the DCIS grade is defined by a combination of nuclear grade, architectural growth pattern and presence of necrosis. The size of the lesion as well as the grade and the clearance margins play a major role in dictating the most appropriate therapy for DCIS.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleonly females |
293218 |
2. Check conditionsNone |
293218 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
260 |
4. Check minimum number of eventsNone |
260 |
5. Include endpointsNone |
260 |
6. Filter based on genotype QC (FinnGen only) |
253 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D05
- Name in latin
- Carcinoma in situ lobulare mammae
Similar endpoints
↥List of similar endpoints to
Carcinoma in situ of breast, lobular
based on the number of shared cases.
Similar with more cases:
- In situ neoplasms
- Neoplasms
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 253 | 253 | - |
| Unadjusted period prevalence (%) | 0.09 | 0.09 | - |
| Median age at first event (years) | 58.86 | 58.86 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 260
- Matched controls
- 2600
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D05.0
ICD-10 Finland
Lobular carcinoma in situ
+∞
307.7
259
*
D05.1
ICD-10 Finland
Intraductal carcinoma in situ
69.9
236.1
142
44
8500/2-C50.9
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS
49.1
114.2
69
19
PJA12
NOMESCO Finland
Sentinel node biopsy
10.8
84.9
139
249
HAC20
NOMESCO Finland
Total mastectomy
12.5
74.4
88
102
HAE20
NOMESCO Finland
Reconstruction of areola and mamilla using graft or flap
27.8
67.7
48
21
HAB99
NOMESCO Finland
Other partial excision of mammary gland
15.7
65.8
63
52
HAE10
NOMESCO Finland
Reconstruction of breast using graft or flap
20.9
63.4
51
30
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.0
55.8
101
192
HA1AA
NOMESCO Finland
X-ray mammography
7.5
55.3
111
235
TQW20
NOMESCO Finland
Tatoe
24.7
54.3
40
19
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
9.8
51.9
70
94
115
Kela drug reimbursment
Breast cancer
6.9
51.8
118
281
HAB40
NOMESCO Finland
Wedge excision of mammary gland
7.7
50.1
90
168
C50.99
ICD-10 Finland
Breast, unspecified
9.1
41.2
57
78
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
6.5
40.8
84
177
8520/2-C50.9
ICD-O-3
Lobular carcinoma in situ, NOS, of breast, NOS
221.4
37.9
38
*
N63
ICD-10 Finland
Unspecified lump in breast
6.8
37.5
71
137
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
12.9
37.1
38
34
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
9.8
34.9
44
53
D48.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Breast
13.8
34.8
34
28
HAB00
NOMESCO Finland
Excision of lesion of mammary gland
8.6
32.0
45
62
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
8.8
31.6
43
57
L02BA01
ATC
tamoxifen; oral
6.5
31.0
59
113
D05.9
ICD-10 Finland
Carcinoma in situ of breast, unspecified
339.8
30.5
30
*
L02BG04
ATC
letrozole; oral
4.8
27.2
77
209
C50.42
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor
9.3
27.2
35
43
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
7.7
26.8
41
62
8520/3-C50.9
ICD-O-3
Lobular carcinoma, NOS, of breast, NOS
11.5
26.7
29
28
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
5.5
26.7
61
138
HAC15
NOMESCO Finland
Subcutaneous mastectomy with excision of mamilla
32.3
26.1
34
12
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
5.3
25.2
59
136
C50
ICD-10 Finland
Malignant neoplasm of breast
7.2
24.3
39
62
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
5.5
22.6
49
105
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
7.7
22.2
33
48
C50.91
ICD-10 Finland
Malignant tumor in another specified localization in ductal mammary gland
8.5
18.6
25
32
HAE99
NOMESCO Finland
Other reconstruction of breast
23.9
18.6
26
12
HAD30
NOMESCO Finland
Reduction mammoplasty with transposition of areola
5.5
17.7
37
76
D24
ICD-10 Finland
Benign neoplasm of breast
7.0
15.7
25
39
WZC00
NOMESCO Finland
Treatment plan or consultation
2.9
15.5
135
713
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.2
14.9
27
48
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
5.1
14.7
33
72
ZZR10
NOMESCO Finland
Flap of skin and muscle
17.0
14.2
22
14
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.0
13.8
43
122
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
5.5
13.7
28
56
A04AA02
ATC
granisetron; systemic, transdermal
4.1
13.6
42
118
XX3DW
NOMESCO Finland
Time consuming IT work
3.3
12.8
56
199
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
6.6
12.7
21
34
ZZF00
NOMESCO Finland
Graft of adipose tissue
17.0
12.3
19
12
WX408
NOMESCO Finland
General anesthesy, balanced
2.6
12.2
98
484
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.1
12.0
35
94
Z85.3
ICD-10 Finland
Personal history of malignant neoplasm of breast
5.9
11.9
22
40
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
11.7
87
413
H02AB02
ATC
dexamethasone; systemic
2.9
11.4
64
262
C50.92
ICD-10 Finland
Malignant tumor in another specified localization in lobular gland, lobular tumor
18.1
11.4
17
10
Z31.5
ICD-10 Finland
Genetic counselling
4.1
11.0
32
86
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
10.6
131
778
HAE05
NOMESCO Finland
Reconstruction of breast using soft tissue and prosthesis
16.9
10.5
16
10
X76
ICPC
Malignant neoplasm breast female
4.9
10.5
24
53
HAE00
NOMESCO Finland
Reconstruction of breast using prosthesis
24.5
10.4
14
6
ZXE30
NOMESCO Finland
More than five and less than seven hours
4.8
9.8
23
52
TQB05
NOMESCO Finland
Puncture of skin of trunk
12.0
9.7
17
15
HA1TE
NOMESCO Finland
Supplementary or limited ultrasound examination of mammary glands
9.2
9.5
19
22
C50.82
ICD-10 Finland
Overall malignant tumor of the mammary gland, lobular tumor
11.3
9.4
17
16
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
5.1
9.2
20
42
Z42.1
ICD-10 Finland
Follow-up care involving plastic surgery of breast
16.3
9.1
14
9
WF003
NOMESCO Finland
Adjuvant radiotherapy
4.6
9.1
22
51
HA4MT
NOMESCO Finland
Labeling mammary gland pathology with X-ray guidance
25.0
9.0
12
5
L02BG03
ATC
anastrozole; oral
5.2
9.0
19
39
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
4.4
8.6
22
53
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
8.0
138
909
X21
ICPC
Breast sympt/compl female other
6.3
7.9
20
34
E05.0
ICD-10 Finland
Thyrotoxicosis with diffuse goitre
4.8
7.8
18
40
HAD60
NOMESCO Finland
Replacement of prosthetic implant in breast
46.4
7.8
9
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
3.1
7.5
33
116
HAD20
NOMESCO Finland
Liposuction of breast
82.3
7.5
8
*
HAB50
NOMESCO Finland
Partial excision of mammary gland with reconstructive operation
3.9
7.4
22
60
HAA10
NOMESCO Finland
Biopsy of mammary gland
16.3
7.3
11
7
Z80.3
ICD-10 Finland
Family history of malignant neoplasm of breast
4.7
7.3
17
38
WX402
NOMESCO Finland
General anaesthesia
2.2
7.2
71
373
ZXA05
NOMESCO Finland
Left side
2.1
7.1
89
514
H03BB01
ATC
carbimazole; oral
3.9
6.9
21
58
8500/2-C50.4
ICD-O-3
Intraductal carcinoma, noninfiltrating, NOS, of upper-outer quadrant of breast
41.2
6.8
8
*
C50.29
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology
12.7
6.6
11
9
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
3.9
6.6
20
55
L02BG06
ATC
exemestane; oral
4.1
6.6
18
46
C50.00
ICD-10 Finland
Malignant tumor of nipple and areola, no histological veryfication
14.8
6.4
10
7
8520/3-C50.4
ICD-O-3
Lobular carcinoma, NOS, of upper-outer quadrant of breast
9.6
6.4
12
13
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
6.2
122
818
L03AA13
ATC
pegfilgrastim; parenteral
2.9
6.2
30
112
C50.81
ICD-10 Finland
Overall malignant tumor of the mammary gland, ductal tumor
5.4
6.1
17
33
HAD99
NOMESCO Finland
Other plastic operation on breast
8.9
6.1
12
14
N64.9
ICD-10 Finland
Disorder of breast, unspecified
10.4
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
41
85
5.54
19.47
2.6
3.6
42.66
27.51
u/ml
0.34
41
85
171
1295
1.94
5.90
7.9
5.7
9.08
9.75
umol/l
0.92
163
1214
51
282
2.01
4.39
4.4
3.9
4.91
11.50
ug/l
1.57
40
239
215
1834
2.00
4.33
9.5
7.2
81.82
79.16
u/l
0.24
208
1701
120
879
1.68
4.04
3.9
3.4
2.40
2.37
mmol/l
2.58
109
768
138
1051
1.67
3.98
2.6
2.3
—
—
—
0
0
167
1355
1.65
3.61
9.7
8.7
3.54
3.85
e9/l
1.36
146
1181
76
526
1.63
3.04
2.2
2.0
—
—
—
0
0
149
1209
1.54
2.96
7.7
5.5
1.23
1.23
mmol/l
0.37
129
1016
16
68
2.44
2.61
2.2
1.5
4.32
5.74
iu/l
—
6
21
253
2411
2.83
2.53
19.3
15.8
70.47
69.50
umol/l
0.30
253
2411
199
1777
1.51
2.10
3.9
4.3
12.72
12.87
mm/h
0.06
181
1620
6
18
3.39
1.75
1.2
1.1
—
—
—
0
0
48
345
1.48
1.58
3.1
2.9
2.75
3.87
e6/l
0.56
23
164
6
21
2.90
1.51
8.3
2.7
9.43
3.43
nmol/l
—
6
21
129
1104
1.33
1.51
6.1
4.7
1.23
1.22
mmol/l
0.33
123
999
68
527
1.39
1.50
1.4
1.4
—
—
—
0
0
5
16
3.16
1.44
1.0
1.1
—
—
—
0
0
56
426
1.40
1.37
3.4
3.8
80.93
155.80
ng/l
0.60
41
325
119
1018
1.31
1.35
4.0
3.7
36.54
35.81
g/l
0.84
108
950
0
37
0.00
1.35
0.0
1.4
—
—
—
0
0
19
115
1.70
1.29
1.3
1.3
—
—
—
0
0
19
115
1.70
1.29
1.2
1.3
—
—
—
0
0
120
1034
1.30
1.28
9.8
10.8
1.13
1.16
inr
0.22
37
313
238
2273
1.56
1.18
14.8
13.0
23.60
20.46
mg/l
0.60
192
1751
50
384
1.37
1.16
2.6
2.6
1.25
1.12
e6/l
0.15
25
203
231
2199
1.45
1.09
16.6
12.7
77.39
78.52
ml/min/173m2
0.41
194
1792
87
732
1.28
1.08
3.7
3.0
33.51
29.01
u/l
0.35
80
696
122
1074
1.26
1.04
2.5
2.3
85.43
80.15
nmol/l
1.11
112
947
43
551
0.74
1.04
1.4
1.2
0.48
2.45
u/ml
—
8
153
10
53
1.92
1.02
1.0
1.9
—
—
—
0
0
44
559
0.74
1.00
2.7
2.5
333.00
6705.03
umol/l
2.75
39
477
78
655
1.27
0.98
2.6
2.9
638.13
966.98
ng/l
0.98
68
549
14
216
0.63
0.90
2.3
2.0
325.21
363.97
nmol/l
0.31
14
206
22
153
1.48
0.89
1.2
1.5
—
—
—
0
0
58
481
1.26
0.80
2.7
2.5
2.48
2.46
mmol/l
0.53
52
427
65
548
1.25
0.78
1.6
1.6
2.00
0.98
mg/l
0.51
58
437
34
429
0.76
0.74
1.9
1.7
1057.31
1255.35
nmol/l
0.78
27
300
11
68
1.64
0.73
1.7
1.9
849.85
219.86
ug/l
0.41
11
61
72
621
1.22
0.71
3.2
3.0
0.31
0.52
e6/l
0.62
48
454
29
223
1.34
0.70
5.6
3.3
1.23
1.24
mmol/l
0.08
29
193
5
27
1.87
0.69
1.0
1.0
—
—
—
0
0
11
70
1.60
0.66
1.1
1.3
—
—
—
0
0
41
335
1.27
0.65
3.0
3.0
0.86
0.81
mmol/l
1.12
41
311
54
631
0.82
0.63
2.9
4.5
0.00
0.00
estimate
-0.00
16
218
87
971
0.84
0.62
2.1
1.9
99.46
99.26
pmol/l
0.01
38
430
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
8
53
1.53
0.59
1.5
1.2
—
—
—
0
0
140
1300
1.17
0.58
3.7
4.0
6.46
6.51
mmol/l
0.14
133
1211
13
90
1.47
0.56
4.3
2.0
—
—
—
0
0
46
534
0.83
0.50
2.3
2.2
2.71
3.30
mg/l
1.01
38
454
7
47
1.50
0.48
1.0
1.1
—
—
—
0
0
30
248
1.24
0.45
2.5
3.4
—
—
—
0
0
82
745
1.15
0.44
2.8
2.1
54.87
54.70
u/l
0.02
72
675
184
1912
0.87
0.43
5.3
4.5
15.12
14.88
pmol/l
0.61
170
1729
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
78
710
1.14
0.41
1.6
1.6
1.28
1.37
mmol/l
0.49
58
591
12
88
1.38
0.40
4.6
2.1
9.53
10.23
g/l
0.34
12
83
87
798
1.14
0.40
3.3
3.0
—
—
—
0
0
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
15
116
1.31
0.38
3.6
6.7
0.85
0.68
%
1.45
15
116
235
2302
1.22
0.37
4.6
4.7
4.95
4.90
mmol/l
0.31
220
2117
41
466
0.86
0.36
1.2
1.3
8.89
12.65
u/ml
0.26
17
182
15
117
1.30
0.36
3.6
6.6
1.18
1.38
%
0.57
15
117
6
42
1.44
0.36
1.5
1.1
—
—
—
0
0
6
45
1.34
0.34
1.2
1.2
—
—
—
0
0
44
492
0.87
0.32
1.8
1.7
162857580.91
473.25
pmol/l
0.49
35
378
24
281
0.84
0.30
2.1
2.1
23.29
21.43
%
0.28
19
235
52
573
0.88
0.30
1.6
1.5
23.93
23.06
nmol/l
0.17
44
476
18
217
0.82
0.30
3.9
2.6
61.43
65.84
ml/min/173m2
—
7
81
122
1158
1.10
0.30
3.0
4.0
0.00
0.00
estimate
-0.00
15
213
42
375
1.14
0.29
1.5
1.4
—
—
—
0
0
26
223
1.18
0.29
2.5
2.2
27.85
28.47
u/l
0.07
20
187
27
311
0.85
0.29
6.5
6.1
—
—
—
0
0
26
224
1.18
0.28
3.4
6.0
5.12
5.24
kpa
0.35
26
219
26
225
1.17
0.27
3.4
6.0
2.06
1.49
mmol/l
0.40
21
193
12
95
1.28
0.26
1.4
1.6
—
—
—
0
0
83
884
0.91
0.26
2.9
4.1
—
—
—
0
0
224
2198
1.14
0.26
4.0
4.1
1.24
1.26
mmol/l
0.19
204
1992
11
138
0.79
0.26
1.5
1.3
—
—
—
0
0
28
247
1.15
0.24
3.7
5.0
105.14
103.73
mmol/l
0.83
28
247
7
92
0.75
0.23
1.3
1.1
—
—
—
0
0
7
92
0.75
0.23
1.3
1.1
—
—
—
0
0
7
92
0.75
0.23
1.1
1.2
—
2.80
—
0
6
120
1150
1.08
0.22
4.4
5.2
0.00
0.00
estimate
-0.00
15
213
21
182
1.17
0.22
1.6
1.1
209.75
130.76
iu/ml
—
10
76
149
1442
1.08
0.21
4.0
2.8
61.48
45.57
u/l
0.68
132
1329
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.3
—
9.50
—
0
10
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
12
0.00
0.21
0.0
1.3
—
132.72
—
0
12
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
11.38
—
0
13
0
14
0.00
0.20
0.0
1.0
—
677.11
—
0
9
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
0.88
—
0
8
0
14
0.00
0.20
0.0
1.0
—
34.89
—
0
9
118
1135
1.07
0.20
3.0
4.0
0.00
0.00
estimate
-0.00
17
228
232
2290
1.12
0.18
4.6
4.6
1.65
1.62
mmol/l
0.50
213
2096
35
320
1.11
0.18
2.3
1.7
28.20
29.47
s
0.94
35
307
82
860
0.93
0.18
3.3
3.5
25.77
60.51
ng/l
0.40
55
603
5
69
0.72
0.17
1.2
1.1
—
38.63
—
0
7
28
307
0.90
0.16
5.1
4.4
32.47
33.51
%
0.31
19
188
232
2294
1.11
0.15
4.9
4.7
5.84
5.84
mmol/l
0.01
213
2080
23
254
0.90
0.15
2.0
1.9
—
—
—
0
0
7
88
0.79
0.15
1.1
1.2
—
3.76
—
0
16
13
112
1.17
0.14
3.4
2.8
0.15
0.12
e6/l
0.10
13
107
26
237
1.11
0.14
4.4
2.2
6.79
6.22
umol/l
0.12
21
205
8
96
0.83
0.14
3.7
2.7
24.79
25.44
mmol/l
—
8
96
8
100
0.79
0.14
3.0
2.7
16.25
1450.35
u/ml
—
8
87
15
132
1.14
0.13
2.5
1.7
—
—
—
0
0
13
113
1.16
0.13
1.4
1.6
—
—
—
0
0
23
251
0.91
0.12
2.0
1.8
—
—
—
0
0
94
970
0.95
0.12
2.4
2.7
132.79
95.04
ug/l
0.66
85
881
237
2351
1.09
0.10
5.2
5.3
2.82
2.86
mmol/l
0.26
220
2149
11
125
0.87
0.10
1.1
1.1
—
—
—
0
0
5
46
1.09
0.09
1.2
1.6
—
—
—
0
0
46
481
0.95
0.09
1.2
1.3
28.61
35.26
iu/ml
0.21
16
168
131
1285
1.04
0.09
2.8
2.7
—
—
—
0
0
6
55
1.09
0.09
1.0
1.2
—
—
—
0
0
6
57
1.05
0.08
1.2
1.4
—
—
—
0
0
7
64
1.10
0.08
1.1
1.2
—
—
—
0
0
222
2203
1.05
0.07
6.1
5.4
1.81
2.46
mu/l
0.62
207
1998
7
81
0.86
0.07
1.4
1.8
—
—
—
0
0
8
92
0.87
0.07
5.0
2.9
40.61
44.07
%
—
8
92
19
180
1.06
0.04
5.1
2.5
66.42
67.23
g/l
0.24
19
167
219
2179
1.03
0.03
5.9
5.7
39.47
39.36
mmol/mol
0.08
203
2006
34
350
0.97
0.03
1.9
1.9
—
—
—
0
0
71
699
1.02
0.03
3.7
3.5
5.06
6.10
mg/mmol
0.13
49
383
10
107
0.93
0.02
1.3
1.6
—
—
—
0
0
18
174
1.04
0.00
1.9
1.7
—
—
—
0
0
15
152
0.99
0.00
1.1
1.2
67.52
160.18
u/ml
2.26
15
142
17
169
1.01
0.00
2.1
2.6
—
22.77
—
0
10
11
115
0.95
0.00
1.5
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
108.80
—
0
5
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
1527.60
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
6
62
0.97
-0.00
12.8
4.7
—
3.38
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
8.0
—
—
—
0
0
8
80
1.00
-0.00
2.1
1.5
0.26
4.50
ug/l
—
8
75
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
7
69
1.01
-0.00
1.1
1.2
—
16.16
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
78
0.89
-0.00
1.3
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
59
1.02
-0.00
1.7
1.9
—
—
—
0
0
6
60
1.00
-0.00
3.3
4.9
3.83
3.78
mmol/l
—
6
60
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
69
0.87
-0.00
1.2
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
5
52
0.96
-0.00
2.6
3.6
62.40
59.62
%
—
5
52
5
50
1.00
-0.00
1.0
1.7
—
—
—
0
0
5
57
0.87
-0.00
1.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_INSITU_BREAST_LOBULAR – Carcinoma in situ of breast, lobular
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).